CYP17A1 Antibodies

Santa Cruz Biotechnology delivers a wide array of CYP17A1 monoclonal antibodies for research in understanding the role of this critical enzyme. CYP17A1 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP17A1, or cytochrome P450 17A1, is essential for steroidogenesis, catalyzing the conversion of pregnenolone and progesterone into androgens and estrogens. The enzyme plays a significant role in the biosynthesis of sex steroids, which are crucial for reproductive health and various physiological processes. Dysregulation of CYP17A1 has been implicated in conditions such as adrenal hyperplasia and hormone-dependent cancers, making it a vital target for therapeutic intervention. Researchers can utilize CYP17A1 monoclonal antibodies to investigate steroid hormone synthesis pathways and their regulation in normal and pathological conditions. Understanding CYP17A1's function and regulation is crucial for developing targeted therapies for hormone-related disorders. Santa Cruz Biotechnology's CYP17A1 monoclonal antibodies enable researchers worldwide to advance our understanding of steroid hormone synthesis and its impact on human health.